Thursday, Apr 17, 2025 · SEC filings
What the smart money revealed on Apr 17
565 insider filings came in. We hid 54 planned (10b5-1) sellers and 442 people whose filings were routine, like grants and tax withholding.
Goldman Sachs Group (GS) Director John Hess bought $2M
3,904 shares on the open market. Not a grant or an option exercise.
Calavo Growers (CVGW) CEO Lecil Cole bought $1.94M
78,930 shares on the open market. Not a grant or an option exercise.
Asana (ASAN) President Dustin Moskovitz bought $792K
50,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 4 checked quarters beat the typical stock 6 months later.
Bow River Capital Evergreen Fund President Jeremy Held bought $446K
9,984 shares on the open market. Not a grant or an option exercise.
Cal-Maine Foods (CALM) Board Chair Adolphus Baker sold $117M
Not marked as a planned 10b5-1 sale. Sold 45% of the shares they held directly. Still holds 1.55M shares.
Concentrix (CNXC) Director Olivier Duha sold $5.28M
Not marked as a planned 10b5-1 sale. Sold 7% of the shares they held directly. Still holds 1.43M shares.
Rubrik (RBRK) Director Ravi Mhatre sold $832K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 14 more real buys
Show 23 more real sales
13F season
Holdings as of Mar 31, 2025 are due May 15
92 funds have filed so far. 80 filed for the quarter before.
Biggest real insider buys, Apr 11–17
Open-market buys by officers and directors, filed in the 7 days up to Apr 17.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.